Latest Blog Posts Tagged "Research News"
August 17, 2017
A new paper shows 67% of study participants who showed smell loss and dopamine loss in the brain developed PD over a four-year period. This strategy could help select people for research studies.
August 14, 2017
MJFF-funded consortium publishes on how best to test for the protein alpha-synuclein in blood and spinal fluid, which could lead to more accurate and replicable results.
August 03, 2017
Recently published results of a Phase II trial evaluating exenatide in Parkinson's disease indicate potential benefit, but more research is needed.
August 02, 2017
Two studies using data from the MJFF-led Parkinson's Progression Markers Initiative point to brain imaging scans that could help advance drug trials.
July 31, 2017
A new study was launched to investigate if man's best friend can play a role in PD diagnosis.
July 28, 2017
The FDA has approved a Phase IIa clinical trial to test the safety and tolerability of nilotinib (Tasigna) in PD.
July 25, 2017
Biotech acquisition could help speed PD therapeutic development.
July 20, 2017
MJFF is partnering to send LRRK2 protein to the International Space Station to grow larger LRRK2 crystals, which can help develop therapies. Michael J. Fox shares a special message on this project.
July 11, 2017
In the latest in our "Getting to a Cure: Science behind the Search" series, we cover the proposed connection between sticky protein alpha-synuclein and the immune system.
July 10, 2017
Five projects targeting alpha-synuclein are in clinical trials with more preparing for testing.